# Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/daclizumab-versus-antithymocyte-globulin-in-high-immunological-risk-renal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christian Noe\[Combining Diaeresis\]l,Daniel Abramowicz,D. Durand,Georges Mourad,Philippe Lang,Miche\[Combining Grave Accent\]le Kessler,Bernard Charpentier,Guy Touchard,F. Berthoux,Pierre Merville,Nacéra Ouali,Jean‐Paul Squifflet,F. Bayle,Karl Martin Wissing,Marc Hazzan |
| Citations | 198 |
| DOI | 10.1681/asn.2008101037 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://jasn.asnjournals.org/content/jnephrol/20/6/1385.full.pdf |
| OpenAlex ID | https://openalex.org/W2135136335 |
| PMID | 19470677 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Karl Martin Wissing](https://scholariq.org/researchers/karl-martin-wissing/)

## Paper journal

- [Journal of the American Society of Nephrology](https://scholariq.org/journals/journal-of-the-american-society-of-nephrology/)

## Paper primary topic

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Paper topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Complement system in diseases](https://scholariq.org/topics/complement-system-in-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.